Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.

615 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The "Chemical Imbalance" Explanation for Depression: Origins, Lay Endorsement, and Clinical Implications (2007, neutral): “Pharmaceutical companies have exponentially increased spending on DTC advertising over the past 15 years, going from expenditures of roughly $12 million in 1989 (Palumbo & Mullins, 2002) to well over $3 billion in 2003 (Kravitz et al., 2005).”
The cost of satisfaction: a national study of patient satisfaction, health care utilization, expenditures, and mortality. (2012, background): “In addition, patients often request discretionary services that are of little or no medical benefit, and physicians frequently accede to these requests, which is associated with higher patient satisfaction.(9,10) Physicians whose compensation is more strongly linked with patient satisfaction are mor”
the ChemiCal imbalanCe explanation of Depression: reDuCing blame at What Cost? (2009, background): “pervasive exposure to pharmaceutical advertisements advancing the chemical imbalance model of depression is common in the united states and affects the treatment-seeking behaviors of consumers and prescribing practices of physicians (kravitz et al., 2005; mintzes et al., 2003).”